FDA Classifies Philips Lumify Ultrasound Safety Notice as Class I Recall After Scanning Failures
The US FDA has classified a safety correction for Philips Lumify diagnostic ultrasound systems as a Class I recall, its most serious category. A software defect can cause the Android or iOS mobile application to fail to recognize a previously registered transducer, unexpectedly demanding re-registration before point-of-care scanning can proceed. Because re-registration requires access to a cellular network or Wi-Fi, scanning capability is blocked in environments lacking connectivity, such as ambulances, aircraft, and remote field settings. In addition, unstable physical USB cable connections between the transducer and mobile devices have caused sudden disconnections during use.
Point-of-care ultrasound is critical for rapid triage, diagnosis, and decision-making in unstable patients. System failures or scanning delays have resulted in eight reported serious injuries and four deaths as of late September 2026. This recall does not require physical removal of the devices from clinical service but mandates updated operating instructions while Philips develops a software update.
Clinicians and emergency response teams are advised to use Lumify devices only in locations with reliable Wi-Fi or cellular coverage unless an alternative ultrasound machine is immediately accessible. Facilities must ensure backup ultrasound equipment is available, distribute the manufacturer's warning to all operators, and display safety notices near affected units.
Key points
- FDA designated the software and connection correction for Philips Lumify ultrasound systems as a Class I recall.
- Software errors trigger unexpected transducer re-registration prompts requiring internet access, preventing scanning in offline settings.
- Transducer USB cables may experience unstable connections or detach from mobile devices during scanning.
- Eight serious injuries and four deaths associated with delays in care have been reported to the manufacturer.
- Operators must ensure backup ultrasound equipment is available and avoid offline use without immediate backup access.
What it means for you
Healthcare providers and emergency teams using Philips Lumify ultrasound devices should ensure immediate access to backup imaging equipment, particularly in pre-hospital or remote settings without reliable cellular or Wi-Fi connectivity. Clinical staff should review the manufacturer's safety instructions regarding re-registration prompts and cable instability while awaiting software updates. Clinicians may check with the Drug Regulatory Authority of Pakistan (DRAP) for local device availability and regulatory guidance.
Diagnostic Ultrasound System Correction: Philips Ultrasound Issues Updated Use Instructions for Lumify Diagnostic Ultrasound System
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.